| A Multicenter, Phase Ib/II Clinical Trial to Evaluate the Efficacy and Safety of Concurrent Combination Therapy of S-531011 Plus Fruquintinib or S-531011 Plus Fruquintinib Plus Pembrolizumab in Patients With MSS/pMMR Colorectal Cancer (NCT07591597) | National Cancer Center Hospital East | 2026-05-01 |
| An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma (NCT07018570) | National Cancer Center Hospital East | 2025-07-24 |
| Recurrent/Metastatic Olfactory Neuroblastoma: Evaluating the Efficacy and Safety of Nivolumab (NCT07100704) | National Cancer Center Hospital East | 2025-04-15 |
| Trastuzumab Deruxtecan Plus Nivolumab Plus Capecitabine Plus Oxaliplatin for HER2 Low Gastric and Gastroesophageal Junction Adenocarcinoma (NCT07529613) | National Cancer Center Hospital East | 2023-12-20 |
| TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer (NCT05646511) | National Cancer Center Hospital East | 2022-11-21 |
| Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy (NCT05394740) | National Cancer Center Hospital East | 2022-06-06 |
| Phase 2 Study of Trastuzumab Deruxtecan in the Neoadjuvant Treatment, or Trastuzumab Deruxtecan Plus Capecitabine Plus Durvalumab(MEDI4736) in the Preoperative and Postoperative Adjuvant Treatment for Patients With HER2 Positive Gastric and Gastroesophageal Junction Adenocarcinoma (NCT05034887) | National Cancer Center Hospital East | 2022-01-31 |
| An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer (NCT04745988) | National Cancer Center Hospital East | 2021-11-11 |
| Olaparib Monotherapy and Olaparib + Pembrolizumab Combination Therapy for Ovarian Cancer (NCT04417192) | National Cancer Center Hospital East | 2020-12-01 |
| Efficacy and Safety of CRT, Durvalumab and Surgery for SST (NCT04465968) | National Cancer Center Hospital East | 2020-09-01 |
| Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection (NCT04457297) | National Cancer Center Hospital East | 2020-07-08 |
| Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY) (NCT05694819) | National Cancer Center Hospital East | 2020-04-17 |
| Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer (NCT04288999) | National Cancer Center Hospital East | 2019-10-01 |
| Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION) (NCT05696548) | National Cancer Center Hospital East | 2019-07-02 |
| Lenvatinib and Pembrolizumab Simultaneous Combination Study (NCT03609359) | National Cancer Center Hospital East | 2018-10-03 |